

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.54433196 |
| 2 | ATP synthesis coupled proton transport (GO:0015986) | 5.54433196 |
| 3 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.47858066 |
| 4 | DNA deamination (GO:0045006) | 5.18023628 |
| 5 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.88950471 |
| 6 | preassembly of GPI anchor in ER membrane (GO:0016254) | 4.38013069 |
| 7 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 4.37917680 |
| 8 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 4.37917680 |
| 9 | respiratory electron transport chain (GO:0022904) | 4.31484589 |
| 10 | protein complex biogenesis (GO:0070271) | 4.29063497 |
| 11 | electron transport chain (GO:0022900) | 4.27893000 |
| 12 | GPI anchor biosynthetic process (GO:0006506) | 4.09686878 |
| 13 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.09080266 |
| 14 | NADH dehydrogenase complex assembly (GO:0010257) | 4.09080266 |
| 15 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.09080266 |
| 16 | protein neddylation (GO:0045116) | 4.06883689 |
| 17 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.06620424 |
| 18 | GPI anchor metabolic process (GO:0006505) | 3.97937873 |
| 19 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.95216806 |
| 20 | platelet dense granule organization (GO:0060155) | 3.91863115 |
| 21 | proteasome assembly (GO:0043248) | 3.89864357 |
| 22 | mannosylation (GO:0097502) | 3.87301167 |
| 23 | chaperone-mediated protein transport (GO:0072321) | 3.72805287 |
| 24 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.51584927 |
| 25 | protein-cofactor linkage (GO:0018065) | 3.49922397 |
| 26 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.45751657 |
| 27 | respiratory chain complex IV assembly (GO:0008535) | 3.38412732 |
| 28 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.34445423 |
| 29 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.34445423 |
| 30 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.30956253 |
| 31 | CENP-A containing nucleosome assembly (GO:0034080) | 3.28996192 |
| 32 | cytochrome complex assembly (GO:0017004) | 3.28900903 |
| 33 | chromatin remodeling at centromere (GO:0031055) | 3.26432650 |
| 34 | cytidine metabolic process (GO:0046087) | 3.25394283 |
| 35 | cytidine catabolic process (GO:0006216) | 3.25394283 |
| 36 | cytidine deamination (GO:0009972) | 3.25394283 |
| 37 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.22441754 |
| 38 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.22438841 |
| 39 | hydrogen ion transmembrane transport (GO:1902600) | 3.21560547 |
| 40 | ATP biosynthetic process (GO:0006754) | 3.15876577 |
| 41 | C-terminal protein lipidation (GO:0006501) | 3.14680482 |
| 42 | proton transport (GO:0015992) | 3.11124943 |
| 43 | kynurenine metabolic process (GO:0070189) | 3.06470331 |
| 44 | hydrogen transport (GO:0006818) | 3.05919315 |
| 45 | L-methionine salvage (GO:0071267) | 3.05470946 |
| 46 | L-methionine biosynthetic process (GO:0071265) | 3.05470946 |
| 47 | amino acid salvage (GO:0043102) | 3.05470946 |
| 48 | peptidyl-histidine modification (GO:0018202) | 3.05438722 |
| 49 | tryptophan metabolic process (GO:0006568) | 3.05046144 |
| 50 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.04552177 |
| 51 | S-adenosylmethionine metabolic process (GO:0046500) | 3.02872738 |
| 52 | cullin deneddylation (GO:0010388) | 3.00985874 |
| 53 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.00856213 |
| 54 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.00608585 |
| 55 | behavioral response to nicotine (GO:0035095) | 2.96339729 |
| 56 | pseudouridine synthesis (GO:0001522) | 2.94757444 |
| 57 | sequestering of actin monomers (GO:0042989) | 2.94519877 |
| 58 | positive regulation of prostaglandin secretion (GO:0032308) | 2.93403153 |
| 59 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.92576530 |
| 60 | ribosomal small subunit assembly (GO:0000028) | 2.92438457 |
| 61 | oxidative phosphorylation (GO:0006119) | 2.91818806 |
| 62 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.89935690 |
| 63 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.89063647 |
| 64 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.89063647 |
| 65 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.89063647 |
| 66 | fucose catabolic process (GO:0019317) | 2.89048572 |
| 67 | L-fucose metabolic process (GO:0042354) | 2.89048572 |
| 68 | L-fucose catabolic process (GO:0042355) | 2.89048572 |
| 69 | protein deneddylation (GO:0000338) | 2.89047988 |
| 70 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.88935538 |
| 71 | rRNA modification (GO:0000154) | 2.87602623 |
| 72 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.87292411 |
| 73 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.87292411 |
| 74 | C-terminal protein amino acid modification (GO:0018410) | 2.85677050 |
| 75 | indole-containing compound catabolic process (GO:0042436) | 2.85281577 |
| 76 | indolalkylamine catabolic process (GO:0046218) | 2.85281577 |
| 77 | tryptophan catabolic process (GO:0006569) | 2.85281577 |
| 78 | protein targeting to mitochondrion (GO:0006626) | 2.83074184 |
| 79 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.82858835 |
| 80 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.81620212 |
| 81 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.81620212 |
| 82 | base-excision repair, AP site formation (GO:0006285) | 2.78664787 |
| 83 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.78289463 |
| 84 | termination of RNA polymerase III transcription (GO:0006386) | 2.78289463 |
| 85 | regulation of mitochondrial translation (GO:0070129) | 2.77823461 |
| 86 | indolalkylamine metabolic process (GO:0006586) | 2.77349544 |
| 87 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.74902491 |
| 88 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.74657890 |
| 89 | establishment of protein localization to mitochondrion (GO:0072655) | 2.73514436 |
| 90 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.73167695 |
| 91 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.72796699 |
| 92 | histone exchange (GO:0043486) | 2.72287960 |
| 93 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.72171004 |
| 94 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.72171004 |
| 95 | tRNA processing (GO:0008033) | 2.71123881 |
| 96 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.70070632 |
| 97 | iron-sulfur cluster assembly (GO:0016226) | 2.68507917 |
| 98 | metallo-sulfur cluster assembly (GO:0031163) | 2.68507917 |
| 99 | maturation of 5.8S rRNA (GO:0000460) | 2.67936016 |
| 100 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.67052710 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.60817254 |
| 2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.22274697 |
| 3 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.52962021 |
| 4 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.24936424 |
| 5 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.19656145 |
| 6 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.12623009 |
| 7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.01877652 |
| 8 | VDR_22108803_ChIP-Seq_LS180_Human | 2.90550290 |
| 9 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.83172080 |
| 10 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.76430232 |
| 11 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.70328997 |
| 12 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.60225685 |
| 13 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.59701372 |
| 14 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.55379758 |
| 15 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.54104608 |
| 16 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.48897139 |
| 17 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.33783919 |
| 18 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.32143148 |
| 19 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.29905993 |
| 20 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.22742303 |
| 21 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.08634832 |
| 22 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.07043406 |
| 23 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.93660877 |
| 24 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.90833248 |
| 25 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.89541873 |
| 26 | EWS_26573619_Chip-Seq_HEK293_Human | 1.80568378 |
| 27 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.72461751 |
| 28 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.65644108 |
| 29 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.63548892 |
| 30 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.61243966 |
| 31 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.60462862 |
| 32 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.58666176 |
| 33 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.58016900 |
| 34 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.53179429 |
| 35 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.50726766 |
| 36 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.50683801 |
| 37 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.50140749 |
| 38 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.48521838 |
| 39 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.42047390 |
| 40 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.41722219 |
| 41 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.41177069 |
| 42 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.38664131 |
| 43 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.38018944 |
| 44 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.37547078 |
| 45 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.36948117 |
| 46 | AR_20517297_ChIP-Seq_VCAP_Human | 1.36532289 |
| 47 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.36038784 |
| 48 | FUS_26573619_Chip-Seq_HEK293_Human | 1.35318557 |
| 49 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.34714635 |
| 50 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.32179607 |
| 51 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.31250574 |
| 52 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.31250574 |
| 53 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.28115732 |
| 54 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.27288184 |
| 55 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.26452562 |
| 56 | GATA3_26560356_Chip-Seq_TH2_Human | 1.24774561 |
| 57 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.22853655 |
| 58 | P300_19829295_ChIP-Seq_ESCs_Human | 1.21414910 |
| 59 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.20695356 |
| 60 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.19413075 |
| 61 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.18168347 |
| 62 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.18168347 |
| 63 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.16043770 |
| 64 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.12699474 |
| 65 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.08996048 |
| 66 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.08201205 |
| 67 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.07661908 |
| 68 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.07661908 |
| 69 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.06749393 |
| 70 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.06005277 |
| 71 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.04797349 |
| 72 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.04622387 |
| 73 | NCOR_22424771_ChIP-Seq_293T_Human | 1.03455364 |
| 74 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.03410396 |
| 75 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.02740487 |
| 76 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.02626146 |
| 77 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.02168444 |
| 78 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.00679141 |
| 79 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.00343861 |
| 80 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.99198819 |
| 81 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99061501 |
| 82 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.98663863 |
| 83 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.97756953 |
| 84 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.97716378 |
| 85 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.96776306 |
| 86 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.96561927 |
| 87 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.95971386 |
| 88 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.95830467 |
| 89 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.95541893 |
| 90 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.92788979 |
| 91 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.92210277 |
| 92 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.91401025 |
| 93 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90505046 |
| 94 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89277069 |
| 95 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88174153 |
| 96 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.86902015 |
| 97 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.86397216 |
| 98 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.86386010 |
| 99 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.86355156 |
| 100 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.85814514 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0006072_abnormal_retinal_apoptosis | 3.44081708 |
| 2 | MP0004147_increased_porphyrin_level | 3.33938613 |
| 3 | MP0005646_abnormal_pituitary_gland | 2.70966007 |
| 4 | MP0000372_irregular_coat_pigmentation | 2.50279089 |
| 5 | MP0002837_dystrophic_cardiac_calcinosis | 2.47602322 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 2.31351764 |
| 7 | MP0008877_abnormal_DNA_methylation | 2.26928896 |
| 8 | MP0005671_abnormal_response_to | 2.25877633 |
| 9 | MP0003786_premature_aging | 2.15793133 |
| 10 | MP0001529_abnormal_vocalization | 2.13151126 |
| 11 | MP0008875_abnormal_xenobiotic_pharmacok | 2.10040208 |
| 12 | MP0001986_abnormal_taste_sensitivity | 1.96861350 |
| 13 | MP0005253_abnormal_eye_physiology | 1.93781219 |
| 14 | MP0008872_abnormal_physiological_respon | 1.93745069 |
| 15 | MP0002736_abnormal_nociception_after | 1.93403213 |
| 16 | MP0001968_abnormal_touch/_nociception | 1.91705226 |
| 17 | MP0004885_abnormal_endolymph | 1.88037462 |
| 18 | MP0005084_abnormal_gallbladder_morpholo | 1.86883626 |
| 19 | MP0005075_abnormal_melanosome_morpholog | 1.86543478 |
| 20 | MP0002102_abnormal_ear_morphology | 1.86136527 |
| 21 | MP0006292_abnormal_olfactory_placode | 1.84206148 |
| 22 | MP0006036_abnormal_mitochondrial_physio | 1.81225722 |
| 23 | MP0005551_abnormal_eye_electrophysiolog | 1.80772771 |
| 24 | MP0008995_early_reproductive_senescence | 1.78815544 |
| 25 | MP0010094_abnormal_chromosome_stability | 1.78669918 |
| 26 | MP0008058_abnormal_DNA_repair | 1.78459916 |
| 27 | MP0003011_delayed_dark_adaptation | 1.78099730 |
| 28 | MP0001835_abnormal_antigen_presentation | 1.77524268 |
| 29 | MP0003195_calcinosis | 1.73163435 |
| 30 | MP0002876_abnormal_thyroid_physiology | 1.70095008 |
| 31 | MP0003724_increased_susceptibility_to | 1.68327183 |
| 32 | MP0009379_abnormal_foot_pigmentation | 1.65277786 |
| 33 | MP0001919_abnormal_reproductive_system | 1.60036843 |
| 34 | MP0004142_abnormal_muscle_tone | 1.52963613 |
| 35 | MP0008789_abnormal_olfactory_epithelium | 1.52174637 |
| 36 | MP0002095_abnormal_skin_pigmentation | 1.47178595 |
| 37 | MP0005389_reproductive_system_phenotype | 1.45354697 |
| 38 | MP0003186_abnormal_redox_activity | 1.42529648 |
| 39 | MP0001905_abnormal_dopamine_level | 1.40612449 |
| 40 | MP0003878_abnormal_ear_physiology | 1.38974966 |
| 41 | MP0005377_hearing/vestibular/ear_phenot | 1.38974966 |
| 42 | MP0002148_abnormal_hypersensitivity_rea | 1.34711782 |
| 43 | MP0005645_abnormal_hypothalamus_physiol | 1.33641786 |
| 44 | MP0006276_abnormal_autonomic_nervous | 1.30875974 |
| 45 | MP0003718_maternal_effect | 1.30786964 |
| 46 | MP0001764_abnormal_homeostasis | 1.25618974 |
| 47 | MP0003880_abnormal_central_pattern | 1.25067845 |
| 48 | MP0006035_abnormal_mitochondrial_morpho | 1.25037450 |
| 49 | MP0003787_abnormal_imprinting | 1.22013092 |
| 50 | MP0005379_endocrine/exocrine_gland_phen | 1.19944316 |
| 51 | MP0003646_muscle_fatigue | 1.17942848 |
| 52 | MP0002163_abnormal_gland_morphology | 1.16750479 |
| 53 | MP0001501_abnormal_sleep_pattern | 1.11712144 |
| 54 | MP0001984_abnormal_olfaction | 1.11537139 |
| 55 | MP0002272_abnormal_nervous_system | 1.09260910 |
| 56 | MP0009745_abnormal_behavioral_response | 1.07960663 |
| 57 | MP0009764_decreased_sensitivity_to | 1.07334399 |
| 58 | MP0004145_abnormal_muscle_electrophysio | 1.06144792 |
| 59 | MP0001188_hyperpigmentation | 1.04065601 |
| 60 | MP0005332_abnormal_amino_acid | 1.03994844 |
| 61 | MP0009785_altered_susceptibility_to | 1.03109580 |
| 62 | MP0001800_abnormal_humoral_immune | 1.02202600 |
| 63 | MP0009046_muscle_twitch | 1.00466304 |
| 64 | MP0005636_abnormal_mineral_homeostasis | 1.00346713 |
| 65 | MP0000685_abnormal_immune_system | 0.99581577 |
| 66 | MP0002638_abnormal_pupillary_reflex | 0.98812326 |
| 67 | MP0005174_abnormal_tail_pigmentation | 0.98615107 |
| 68 | MP0000427_abnormal_hair_cycle | 0.97847346 |
| 69 | MP0005167_abnormal_blood-brain_barrier | 0.97669934 |
| 70 | MP0005000_abnormal_immune_tolerance | 0.97655614 |
| 71 | MP0000631_abnormal_neuroendocrine_gland | 0.94346608 |
| 72 | MP0003866_abnormal_defecation | 0.94333111 |
| 73 | MP0005360_urolithiasis | 0.87928582 |
| 74 | MP0002938_white_spotting | 0.87705921 |
| 75 | MP0001486_abnormal_startle_reflex | 0.86472430 |
| 76 | MP0005410_abnormal_fertilization | 0.86166558 |
| 77 | MP0002723_abnormal_immune_serum | 0.85674527 |
| 78 | MP0002138_abnormal_hepatobiliary_system | 0.83475634 |
| 79 | MP0002751_abnormal_autonomic_nervous | 0.83301476 |
| 80 | MP0003252_abnormal_bile_duct | 0.81742267 |
| 81 | MP0002452_abnormal_antigen_presenting | 0.79047832 |
| 82 | MP0005499_abnormal_olfactory_system | 0.78007279 |
| 83 | MP0005394_taste/olfaction_phenotype | 0.78007279 |
| 84 | MP0001929_abnormal_gametogenesis | 0.77937255 |
| 85 | MP0002160_abnormal_reproductive_system | 0.77223425 |
| 86 | MP0002234_abnormal_pharynx_morphology | 0.76459093 |
| 87 | MP0002210_abnormal_sex_determination | 0.76254654 |
| 88 | MP0002909_abnormal_adrenal_gland | 0.75445274 |
| 89 | MP0000465_gastrointestinal_hemorrhage | 0.74206698 |
| 90 | MP0005195_abnormal_posterior_eye | 0.73761390 |
| 91 | MP0000653_abnormal_sex_gland | 0.73557316 |
| 92 | MP0001765_abnormal_ion_homeostasis | 0.73414253 |
| 93 | MP0001485_abnormal_pinna_reflex | 0.73262042 |
| 94 | MP0001819_abnormal_immune_cell | 0.72655140 |
| 95 | MP0000230_abnormal_systemic_arterial | 0.72266240 |
| 96 | MP0002420_abnormal_adaptive_immunity | 0.71526246 |
| 97 | MP0001145_abnormal_male_reproductive | 0.71358545 |
| 98 | MP0000639_abnormal_adrenal_gland | 0.71188439 |
| 99 | MP0003137_abnormal_impulse_conducting | 0.68882297 |
| 100 | MP0000689_abnormal_spleen_morphology | 0.68510719 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 4.86757993 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.35784031 |
| 3 | Mitochondrial inheritance (HP:0001427) | 4.35528019 |
| 4 | Acute encephalopathy (HP:0006846) | 4.21054270 |
| 5 | Progressive macrocephaly (HP:0004481) | 4.13780372 |
| 6 | Hepatocellular necrosis (HP:0001404) | 4.07306206 |
| 7 | Increased CSF lactate (HP:0002490) | 4.01745300 |
| 8 | 3-Methylglutaconic aciduria (HP:0003535) | 3.73075202 |
| 9 | Abnormality of alanine metabolism (HP:0010916) | 3.70046643 |
| 10 | Hyperalaninemia (HP:0003348) | 3.70046643 |
| 11 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.70046643 |
| 12 | Hepatic necrosis (HP:0002605) | 3.61478915 |
| 13 | Congenital, generalized hypertrichosis (HP:0004540) | 3.61010651 |
| 14 | Lipid accumulation in hepatocytes (HP:0006561) | 3.38995467 |
| 15 | Methylmalonic acidemia (HP:0002912) | 3.29435987 |
| 16 | Increased hepatocellular lipid droplets (HP:0006565) | 3.26896983 |
| 17 | Cerebral edema (HP:0002181) | 3.14383350 |
| 18 | Abnormality of midbrain morphology (HP:0002418) | 3.09870089 |
| 19 | Molar tooth sign on MRI (HP:0002419) | 3.09870089 |
| 20 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.05565620 |
| 21 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.05565620 |
| 22 | Pancreatic cysts (HP:0001737) | 2.99067760 |
| 23 | Increased serum lactate (HP:0002151) | 2.98761329 |
| 24 | IgG deficiency (HP:0004315) | 2.87966319 |
| 25 | Congenital stationary night blindness (HP:0007642) | 2.83675039 |
| 26 | True hermaphroditism (HP:0010459) | 2.83105840 |
| 27 | Lactic acidosis (HP:0003128) | 2.72274773 |
| 28 | Pancreatic fibrosis (HP:0100732) | 2.69862287 |
| 29 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.69149991 |
| 30 | Methylmalonic aciduria (HP:0012120) | 2.65158470 |
| 31 | Optic disc pallor (HP:0000543) | 2.62902648 |
| 32 | Medial flaring of the eyebrow (HP:0010747) | 2.60748839 |
| 33 | Severe combined immunodeficiency (HP:0004430) | 2.59407589 |
| 34 | Renal Fanconi syndrome (HP:0001994) | 2.57443403 |
| 35 | Abolished electroretinogram (ERG) (HP:0000550) | 2.53740878 |
| 36 | Nephronophthisis (HP:0000090) | 2.48788812 |
| 37 | Increased intramyocellular lipid droplets (HP:0012240) | 2.46087345 |
| 38 | Hyperglycinemia (HP:0002154) | 2.44491368 |
| 39 | Respiratory failure (HP:0002878) | 2.37935396 |
| 40 | Lethargy (HP:0001254) | 2.31278824 |
| 41 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.27738723 |
| 42 | Thyroiditis (HP:0100646) | 2.24892268 |
| 43 | Hypothermia (HP:0002045) | 2.23204902 |
| 44 | Type 2 muscle fiber atrophy (HP:0003554) | 2.21262771 |
| 45 | Increased muscle lipid content (HP:0009058) | 2.21246011 |
| 46 | Leukodystrophy (HP:0002415) | 2.21143968 |
| 47 | Renal cortical cysts (HP:0000803) | 2.20703712 |
| 48 | Congenital primary aphakia (HP:0007707) | 2.20610214 |
| 49 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.18268494 |
| 50 | Type II lissencephaly (HP:0007260) | 2.16128860 |
| 51 | Exertional dyspnea (HP:0002875) | 2.13331919 |
| 52 | Gait imbalance (HP:0002141) | 2.13328172 |
| 53 | Constricted visual fields (HP:0001133) | 2.11713836 |
| 54 | Abnormality of the renal cortex (HP:0011035) | 2.10442448 |
| 55 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.08736555 |
| 56 | Progressive microcephaly (HP:0000253) | 2.07681488 |
| 57 | Nephrogenic diabetes insipidus (HP:0009806) | 2.07110958 |
| 58 | Exercise intolerance (HP:0003546) | 2.06066420 |
| 59 | Abnormality of serum amino acid levels (HP:0003112) | 2.00802628 |
| 60 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.97556501 |
| 61 | CNS demyelination (HP:0007305) | 1.95333577 |
| 62 | Combined immunodeficiency (HP:0005387) | 1.95010229 |
| 63 | Pendular nystagmus (HP:0012043) | 1.93940070 |
| 64 | Abnormality of the renal medulla (HP:0100957) | 1.93444766 |
| 65 | Abnormality of the prostate (HP:0008775) | 1.92821789 |
| 66 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.89947685 |
| 67 | Attenuation of retinal blood vessels (HP:0007843) | 1.89685391 |
| 68 | Abnormal number of erythroid precursors (HP:0012131) | 1.89601464 |
| 69 | Short tibia (HP:0005736) | 1.89126509 |
| 70 | Delayed CNS myelination (HP:0002188) | 1.86861948 |
| 71 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.86349384 |
| 72 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.86193949 |
| 73 | Dicarboxylic aciduria (HP:0003215) | 1.86193949 |
| 74 | Retinal dysplasia (HP:0007973) | 1.86045297 |
| 75 | Sclerocornea (HP:0000647) | 1.85765770 |
| 76 | Aplastic anemia (HP:0001915) | 1.85344396 |
| 77 | Degeneration of anterior horn cells (HP:0002398) | 1.84940642 |
| 78 | Abnormality of the anterior horn cell (HP:0006802) | 1.84940642 |
| 79 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.83153053 |
| 80 | Abnormality of glycine metabolism (HP:0010895) | 1.83153053 |
| 81 | Type I transferrin isoform profile (HP:0003642) | 1.82820099 |
| 82 | Abnormality of vitamin B metabolism (HP:0004340) | 1.82090895 |
| 83 | Hypoplasia of the uterus (HP:0000013) | 1.81934327 |
| 84 | Abnormal protein glycosylation (HP:0012346) | 1.80804776 |
| 85 | Abnormal glycosylation (HP:0012345) | 1.80804776 |
| 86 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.80804776 |
| 87 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.80804776 |
| 88 | Cleft eyelid (HP:0000625) | 1.80099633 |
| 89 | Pancytopenia (HP:0001876) | 1.79247449 |
| 90 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.78483899 |
| 91 | Hyperglycinuria (HP:0003108) | 1.77407391 |
| 92 | Abnormality of B cell number (HP:0010975) | 1.77141136 |
| 93 | Ketosis (HP:0001946) | 1.76010073 |
| 94 | Muscle fiber atrophy (HP:0100295) | 1.74523766 |
| 95 | Panhypogammaglobulinemia (HP:0003139) | 1.73651194 |
| 96 | B lymphocytopenia (HP:0010976) | 1.73613540 |
| 97 | Absent thumb (HP:0009777) | 1.72888177 |
| 98 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.71367419 |
| 99 | Abnormality of the fovea (HP:0000493) | 1.67523826 |
| 100 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.65701442 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ZAK | 3.20724935 |
| 2 | MAP4K2 | 3.09463913 |
| 3 | TXK | 3.03677745 |
| 4 | BCKDK | 2.60591046 |
| 5 | TLK1 | 2.38993910 |
| 6 | TAOK3 | 2.34469275 |
| 7 | EIF2AK3 | 2.22408166 |
| 8 | VRK2 | 2.21139741 |
| 9 | NUAK1 | 2.20591471 |
| 10 | GRK1 | 2.10996188 |
| 11 | ADRBK2 | 2.08103920 |
| 12 | TESK2 | 1.99600976 |
| 13 | FRK | 1.98485948 |
| 14 | STK16 | 1.92613811 |
| 15 | INSRR | 1.80109285 |
| 16 | BMPR1B | 1.74444484 |
| 17 | MST4 | 1.69464196 |
| 18 | ERBB3 | 1.61367259 |
| 19 | SRPK1 | 1.55501202 |
| 20 | BUB1 | 1.53690352 |
| 21 | WNK3 | 1.47831318 |
| 22 | CSNK1G3 | 1.47736991 |
| 23 | TRIM28 | 1.46507871 |
| 24 | EIF2AK1 | 1.45507147 |
| 25 | KDR | 1.40866827 |
| 26 | PLK2 | 1.36584097 |
| 27 | BMPR2 | 1.36400060 |
| 28 | OXSR1 | 1.35932947 |
| 29 | PLK4 | 1.35143681 |
| 30 | CDK8 | 1.31820732 |
| 31 | GRK6 | 1.28573424 |
| 32 | WNK4 | 1.28432201 |
| 33 | VRK1 | 1.28326146 |
| 34 | RPS6KA4 | 1.28029739 |
| 35 | PINK1 | 1.25519264 |
| 36 | NEK1 | 1.24284968 |
| 37 | CSNK1G2 | 1.21059324 |
| 38 | CCNB1 | 1.14404067 |
| 39 | DYRK2 | 1.11806698 |
| 40 | KIT | 1.08427746 |
| 41 | CSNK1G1 | 1.07062949 |
| 42 | STK39 | 1.05567709 |
| 43 | PLK3 | 1.03272208 |
| 44 | CSNK1A1L | 1.01152081 |
| 45 | GRK7 | 1.01142958 |
| 46 | BCR | 0.99884203 |
| 47 | TIE1 | 0.99306160 |
| 48 | PHKG1 | 0.94089501 |
| 49 | PHKG2 | 0.94089501 |
| 50 | NME1 | 0.91606692 |
| 51 | EIF2AK2 | 0.88494624 |
| 52 | MAP2K7 | 0.88190747 |
| 53 | DAPK2 | 0.87713900 |
| 54 | RPS6KA5 | 0.86405533 |
| 55 | CDC7 | 0.85779941 |
| 56 | LIMK1 | 0.82965197 |
| 57 | IKBKB | 0.81679584 |
| 58 | CDK19 | 0.78426949 |
| 59 | MAPK13 | 0.77811198 |
| 60 | DAPK1 | 0.75982448 |
| 61 | MAP3K12 | 0.75876248 |
| 62 | TEC | 0.74732842 |
| 63 | SYK | 0.71757159 |
| 64 | MAP2K2 | 0.70369576 |
| 65 | MAP3K4 | 0.70133490 |
| 66 | ATR | 0.69731614 |
| 67 | AURKB | 0.68650786 |
| 68 | MAP4K1 | 0.65206570 |
| 69 | MKNK1 | 0.63500405 |
| 70 | ITK | 0.62262242 |
| 71 | DYRK3 | 0.61241516 |
| 72 | CSF1R | 0.60808312 |
| 73 | TNK2 | 0.58020231 |
| 74 | LYN | 0.56369954 |
| 75 | PRKCE | 0.55506090 |
| 76 | FES | 0.55318681 |
| 77 | CSNK2A1 | 0.55215106 |
| 78 | ACVR1B | 0.53209465 |
| 79 | PLK1 | 0.51273218 |
| 80 | MAPKAPK3 | 0.49129443 |
| 81 | PRKCQ | 0.49119335 |
| 82 | CHEK2 | 0.48217643 |
| 83 | ADRBK1 | 0.48187222 |
| 84 | GRK5 | 0.46547194 |
| 85 | FLT3 | 0.45676595 |
| 86 | PIM2 | 0.45517252 |
| 87 | PIM1 | 0.45135850 |
| 88 | CSNK1A1 | 0.44828526 |
| 89 | CSNK2A2 | 0.44592997 |
| 90 | MAP2K6 | 0.44333950 |
| 91 | EPHA3 | 0.44267920 |
| 92 | TSSK6 | 0.43883032 |
| 93 | MATK | 0.43501031 |
| 94 | ABL2 | 0.42256179 |
| 95 | PDK2 | 0.41106449 |
| 96 | IGF1R | 0.37845159 |
| 97 | OBSCN | 0.37621636 |
| 98 | MUSK | 0.37429862 |
| 99 | LCK | 0.36972360 |
| 100 | PRKACA | 0.36889710 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.08893171 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.74830706 |
| 3 | Protein export_Homo sapiens_hsa03060 | 3.40657811 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.39430503 |
| 5 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.78020285 |
| 6 | Ribosome_Homo sapiens_hsa03010 | 2.34371652 |
| 7 | RNA polymerase_Homo sapiens_hsa03020 | 2.25903310 |
| 8 | Huntingtons disease_Homo sapiens_hsa05016 | 2.21978594 |
| 9 | Alzheimers disease_Homo sapiens_hsa05010 | 2.20461007 |
| 10 | Homologous recombination_Homo sapiens_hsa03440 | 2.09975136 |
| 11 | Asthma_Homo sapiens_hsa05310 | 2.05434900 |
| 12 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.01964405 |
| 13 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.92155973 |
| 14 | Mismatch repair_Homo sapiens_hsa03430 | 1.91273883 |
| 15 | DNA replication_Homo sapiens_hsa03030 | 1.90869416 |
| 16 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.86257172 |
| 17 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.85209094 |
| 18 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.84303490 |
| 19 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.61907873 |
| 20 | RNA degradation_Homo sapiens_hsa03018 | 1.47351499 |
| 21 | Spliceosome_Homo sapiens_hsa03040 | 1.45856776 |
| 22 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.45802393 |
| 23 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.42512134 |
| 24 | Phototransduction_Homo sapiens_hsa04744 | 1.40871801 |
| 25 | Basal transcription factors_Homo sapiens_hsa03022 | 1.40622774 |
| 26 | Base excision repair_Homo sapiens_hsa03410 | 1.40470608 |
| 27 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.40042820 |
| 28 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.34693484 |
| 29 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.34692260 |
| 30 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.34225834 |
| 31 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.34036018 |
| 32 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.33657278 |
| 33 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.30408071 |
| 34 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.28229968 |
| 35 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.26337975 |
| 36 | Allograft rejection_Homo sapiens_hsa05330 | 1.25442493 |
| 37 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.23709639 |
| 38 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.23377929 |
| 39 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.21066963 |
| 40 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.18927039 |
| 41 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.13087264 |
| 42 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.11906128 |
| 43 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.08950653 |
| 44 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.08019353 |
| 45 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.07810970 |
| 46 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.06311207 |
| 47 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.00673860 |
| 48 | Purine metabolism_Homo sapiens_hsa00230 | 0.99739775 |
| 49 | Peroxisome_Homo sapiens_hsa04146 | 0.99205693 |
| 50 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.90650656 |
| 51 | RNA transport_Homo sapiens_hsa03013 | 0.89180383 |
| 52 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.88463799 |
| 53 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.86899803 |
| 54 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.86794989 |
| 55 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.86415918 |
| 56 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.82306625 |
| 57 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.81558164 |
| 58 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.81434569 |
| 59 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.74442038 |
| 60 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.74033876 |
| 61 | Metabolic pathways_Homo sapiens_hsa01100 | 0.72771254 |
| 62 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.72592737 |
| 63 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.71499851 |
| 64 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.70595982 |
| 65 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.70239641 |
| 66 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.66041995 |
| 67 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.64920264 |
| 68 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.64534208 |
| 69 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.63638297 |
| 70 | Sulfur relay system_Homo sapiens_hsa04122 | 0.60733159 |
| 71 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.60549357 |
| 72 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.59932398 |
| 73 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.59617374 |
| 74 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.58162078 |
| 75 | Nicotine addiction_Homo sapiens_hsa05033 | 0.57178013 |
| 76 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.56209368 |
| 77 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.54287011 |
| 78 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.54141285 |
| 79 | Olfactory transduction_Homo sapiens_hsa04740 | 0.53171538 |
| 80 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.52899566 |
| 81 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.50730952 |
| 82 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.49826397 |
| 83 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.48949413 |
| 84 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.46771379 |
| 85 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.46176267 |
| 86 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.44925378 |
| 87 | Retinol metabolism_Homo sapiens_hsa00830 | 0.42482028 |
| 88 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.39658816 |
| 89 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.39609428 |
| 90 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.39244597 |
| 91 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.39180789 |
| 92 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.38859882 |
| 93 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.37724463 |
| 94 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.37181169 |
| 95 | Morphine addiction_Homo sapiens_hsa05032 | 0.36657561 |
| 96 | Taste transduction_Homo sapiens_hsa04742 | 0.36072989 |
| 97 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.35598711 |
| 98 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.35068185 |
| 99 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.33995910 |
| 100 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.28848300 |

